Alteus Biogenics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.50 Cr
- Satisfied Charges ₹ 5.00 M
- Revenue Growth 34.74%
- Profit Growth 2.80%
- Ebitda 9.33%
- Net Worth 37.61%
- Total Assets 59.87%
About Alteus Biogenics
Alteus Biogenics Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 May 2008 and has a history of 16 years and eight months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹40.50 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abesh Mazumder, Nibedita Chakraborty, Debasish Mitra, and Two other members serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100WB2008PTC125979
-
Company No.
125979
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 May 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Alteus Biogenics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abesh Mazumder
|
Director | 26-May-2008 | Current |
|
Nibedita Chakraborty
|
Director | 01-Jan-2014 | Current |
|
Debasish Mitra
|
Director | 22-May-2008 | Current |
|
Reetwija Chakraborty
|
Director | 01-Jan-2014 | Current |
|
Soma Dev
|
Director | 01-Jan-2014 | Current |
Financial Performance of Alteus Biogenics.
Alteus Biogenics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.74% increase. The company also saw a slight improvement in profitability, with a 2.8% increase in profit. The company's net worth Soared by an impressive increase of 37.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alteus Biogenics?
In 2023, Alteus Biogenics had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aura Agencies Private LimitedAbesh Mazumder is a mutual person
-
Stance Biogenics Private Limited
Abesh Mazumder is a mutual person
-
Delon Distribution And Logistics Private Limited
Abesh Mazumder is a mutual person
-
Devysun Sales & Distribution Private Limited
Abesh Mazumder is a mutual person
-
Alteus Global Limited
Nibedita Chakraborty, Debasish Mitra and 1 more are mutual person
-
G99 Pharmacy Limited
Nibedita Chakraborty, Debasish Mitra and 1 more are mutual person
Charges (Loans)
₹405.04 M
₹5.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 27.50 Cr
- Axis Bank Limited : 12.00 Cr
- Deutsche Bank Ag : 0.94 Cr
- Union Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2023 | Hdfc Bank Limited | ₹17.00 Cr | Open |
| 27 Mar 2023 | Axis Bank Limited | ₹12.00 Cr | Open |
| 16 Sep 2015 | Deutsche Bank Ag | ₹3.44 M | Open |
| 15 Jan 2014 | Deutsche Bank Ag | ₹6.00 M | Open |
| 10 Jun 2013 | Hdfc Bank Limited | ₹10.50 Cr | Open |
How Many Employees Work at Alteus Biogenics?
Alteus Biogenics has a workforce of 292 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alteus Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alteus Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
